The novel mu-opioid antagonist, GSK1521498, reduces ethanol consumption in C57BL/6J mice

RATIONALE: Using the drinking-in-the-dark (DID) model, we compared the effects of a novel mu-opioid receptor antagonist, GSK1521498, with naltrexone, a licensed treatment of alcohol dependence, on ethanol consumption in mice. OBJECTIVE: We test the ability of GSK1521498 to reduce alcohol consumption...

Descripción completa

Detalles Bibliográficos
Autores principales: Ripley, Tamzin L., Sanchez-Roige, Sandra, Bullmore, Edward T., Mugnaini, Manolo, Maltby, Kay, Miller, Sam R., Wille, David R., Nathan, Pradeep, Stephens, David N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2015
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4537503/
https://www.ncbi.nlm.nih.gov/pubmed/26141191
http://dx.doi.org/10.1007/s00213-015-3995-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4537503/
https://www.ncbi.nlm.nih.gov/pubmed/26141191
http://dx.doi.org/10.1007/s00213-015-3995-x

Ejemplares similares